← Browse by Condition
Medical Condition
refractory acute undifferentiated leukemia
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2, Phase 1
NCT06928662 Phase 1, Phase 2
Recruiting
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
Enrollment
36 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT04375631 Phase 1
Recruiting
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Enrollment
120 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center